The U.S. Food and Drug Administration has approved a new treatment for advanced breast cancer. Drugmaker Eli Lilly announced Sept. 25 the approval of Inluriyo, an oral estrogen receptor antagonist, to treat adults with specific types of the disease. Those types include estrogen receptor-positive (ER+), human epidermal growth factor receptor …
Read More »
Decades after Marines and families at North Carolina’s Camp Lejeune bathed and drank in poisoned water, the law meant to bring them justice has stalled. The 2022 Camp Lejeune Justice Act — intended to finally allow victims their day in court — has instead become mired in legal backlogs and …
Read More »
Artificial intelligence is making its mark on the future of cancer care. One of the newest applications for the technology is pinpointing hard-to-detect breast cancer. Researchers at Ohio State University’s Comprehensive Cancer Center (OSUCCC) – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are using AI in …
Read More »